In prostate cancer (PCa), PTEN is frequently lost by deletion of the 10q23 region in tumors, which has been described several years ago (1–4), and prostate-specific deletion of Pten in mice leads to PCa development (5). The gene discussed is PTEN; the disease is posterior cortical atrophy.